Witnessing the stock’s movement on the chart, on Thursday, Elevation Oncology Inc (NASDAQ: ELEV) set off with pace as it heaved 5.27% to $0.59, before settling in for the price of $0.56 at the close. Taking a more long-term approach, ELEV posted a 52-week range of $0.44-$5.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -52.56%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 36.19%. This publicly-traded company’s shares outstanding now amounts to $59.12 million, simultaneously with a float of $52.02 million. The organization now has a market capitalization sitting at $35.09 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6048, while the 200-day Moving Average is $2.1125.
Elevation Oncology Inc (ELEV) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Elevation Oncology Inc’s current insider ownership accounts for 12.00%, in contrast to 66.17% institutional ownership.
Elevation Oncology Inc (ELEV) Earnings and Revenue Records
Elevation Oncology Inc’s EPS increase for this current 12-month fiscal period is 36.19% and is forecasted to reach -0.91 in the upcoming year.
Elevation Oncology Inc (NASDAQ: ELEV) Trading Performance Indicators
Let’s observe the current performance indicators for Elevation Oncology Inc (ELEV). It’s Quick Ratio in the last reported quarter now stands at 17.77. The Stock has managed to achieve an average true range (ATR) of 0.07.
In the same vein, ELEV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.81, a figure that is expected to reach -0.23 in the next quarter, and analysts are predicting that it will be -0.91 at the market close of one year from today.
Technical Analysis of Elevation Oncology Inc (ELEV)
Going through the that latest performance of [Elevation Oncology Inc, ELEV]. Its last 5-days volume of 1.2 million was inferior to the volume of 1.48 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 15.17% While, its Average True Range was 0.0675.
Raw Stochastic average of Elevation Oncology Inc (ELEV) in the period of the previous 100 days is set at 17.66%, which indicates a major fall in contrast to 18.32% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 94.48% that was lower than 175.01% volatility it exhibited in the past 100-days period.
